NYSEAMERICAN:XXII

22nd Century Group Competitors

$3.14
-0.07 (-2.18 %)
(As of 04/19/2021 02:26 PM ET)
Add
Compare
Today's Range
$3.02
Now: $3.14
$3.29
50-Day Range
$2.11
MA: $2.29
$2.54
52-Week Range
$0.55
Now: $3.14
$4.66
Volume57,951 shs
Average Volume3.24 million shs
Market Capitalization$478.53 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

22nd Century Group (NYSEAMERICAN:XXII) Vs. IIPR, GRWG, KSHB, NSAV, TRTC, and CANN

Should you be buying XXII stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to 22nd Century Group, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), KushCo (KSHB), NSAV (NSAV), Terra Tech (TRTC), and General Cannabis (CANN).

22nd Century Group (NYSEAMERICAN:XXII) and Innovative Industrial Properties (NYSE:IIPR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Institutional and Insider Ownership

74.9% of Innovative Industrial Properties shares are held by institutional investors. 2.9% of Innovative Industrial Properties shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares 22nd Century Group and Innovative Industrial Properties' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
22nd Century GroupN/AN/AN/AN/AN/A
Innovative Industrial Properties$44.67 million96.71$23.48 million$3.2755.22

Innovative Industrial Properties has higher revenue and earnings than 22nd Century Group.

Profitability

This table compares 22nd Century Group and Innovative Industrial Properties' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
22nd Century GroupN/AN/AN/A
Innovative Industrial Properties55.71%6.05%4.82%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and Innovative Industrial Properties, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
22nd Century Group00103.00
Innovative Industrial Properties02502.71

Innovative Industrial Properties has a consensus target price of $192.4286, indicating a potential upside of 6.23%. Given Innovative Industrial Properties' higher possible upside, analysts plainly believe Innovative Industrial Properties is more favorable than 22nd Century Group.

Summary

Innovative Industrial Properties beats 22nd Century Group on 8 of the 9 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and GrowGeneration (NASDAQ:GRWG) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Institutional and Insider Ownership

51.3% of GrowGeneration shares are held by institutional investors. 13.6% of GrowGeneration shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares 22nd Century Group and GrowGeneration's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
22nd Century GroupN/AN/AN/AN/AN/A
GrowGeneration$79 million33.24$1.88 million$0.10449.20

GrowGeneration has higher revenue and earnings than 22nd Century Group.

Profitability

This table compares 22nd Century Group and GrowGeneration's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
22nd Century GroupN/AN/AN/A
GrowGeneration2.14%4.68%3.53%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and GrowGeneration, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
22nd Century Group00103.00
GrowGeneration03502.63

GrowGeneration has a consensus target price of $49.5714, indicating a potential upside of 10.50%. Given GrowGeneration's higher possible upside, analysts plainly believe GrowGeneration is more favorable than 22nd Century Group.

Summary

GrowGeneration beats 22nd Century Group on 8 of the 9 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and KushCo (OTCMKTS:KSHB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Institutional and Insider Ownership

0.0% of KushCo shares are held by institutional investors. 17.3% of KushCo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares 22nd Century Group and KushCo's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
22nd Century GroupN/AN/AN/AN/AN/A
KushCo$113.84 million1.65$-77,660,000.00($0.68)-1.74

22nd Century Group has higher earnings, but lower revenue than KushCo.

Profitability

This table compares 22nd Century Group and KushCo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
22nd Century GroupN/AN/AN/A
KushCo-65.89%-47.95%-31.39%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and KushCo, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
22nd Century Group00103.00
KushCo01302.75

KushCo has a consensus target price of $1.8750, indicating a potential upside of 58.90%. Given KushCo's higher possible upside, analysts plainly believe KushCo is more favorable than 22nd Century Group.

Summary

KushCo beats 22nd Century Group on 5 of the 9 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and NSAV (OTCMKTS:NSAV) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Earnings & Valuation

This table compares 22nd Century Group and NSAV's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
22nd Century GroupN/AN/AN/AN/AN/A
NSAVN/AN/AN/AN/AN/A

Profitability

This table compares 22nd Century Group and NSAV's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
22nd Century GroupN/AN/AN/A
NSAVN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and NSAV, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
22nd Century Group00103.00
NSAV0000N/A

Summary

22nd Century Group beats NSAV on 1 of the 1 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and Terra Tech (OTCMKTS:TRTC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Institutional and Insider Ownership

0.1% of Terra Tech shares are held by institutional investors. 6.7% of Terra Tech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares 22nd Century Group and Terra Tech's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
22nd Century GroupN/AN/AN/AN/AN/A
Terra Tech$28.05 million2.15$-46,930,000.00N/AN/A

22nd Century Group has higher earnings, but lower revenue than Terra Tech.

Profitability

This table compares 22nd Century Group and Terra Tech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
22nd Century GroupN/AN/AN/A
Terra Tech-261.88%-110.38%-62.41%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and Terra Tech, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
22nd Century Group00103.00
Terra Tech0000N/A

Summary

22nd Century Group beats Terra Tech on 4 of the 7 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and General Cannabis (OTCMKTS:CANN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Profitability

This table compares 22nd Century Group and General Cannabis' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
22nd Century GroupN/AN/AN/A
General Cannabis-167.65%N/A-171.06%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and General Cannabis, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
22nd Century Group00103.00
General Cannabis0000N/A

Earnings & Valuation

This table compares 22nd Century Group and General Cannabis' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
22nd Century GroupN/AN/AN/AN/AN/A
General Cannabis$3.67 million11.51$-15,480,000.00N/AN/A

22nd Century Group has higher earnings, but lower revenue than General Cannabis.

Summary

22nd Century Group beats General Cannabis on 3 of the 4 factors compared between the two stocks.


22nd Century Group Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Innovative Industrial Properties logo
IIPR
Innovative Industrial Properties
1.8$180.56-2.4%$4.42 billion$44.67 million58.43Analyst Revision
GrowGeneration logo
GRWG
GrowGeneration
1.7$44.92-4.9%$2.75 billion$79 million898.58Insider Selling
KushCo logo
KSHB
KushCo
1.3$1.18-0.0%$187.47 million$113.84 million-1.97Gap Up
NSAV logo
NSAV
NSAV
0.3$0.02-1.1%$104.60 millionN/A0.00Gap Up
Terra Tech logo
TRTC
Terra Tech
0.7$0.26-3.7%$60.19 million$28.05 million0.00Decrease in Short Interest
Gap Up
General Cannabis logo
CANN
General Cannabis
0.6$0.68-4.4%$42.26 million$3.67 million0.00Gap Up
PVSP
Pervasip
0.4$0.01-0.0%$39.26 millionN/A0.00Increase in Short Interest
News Coverage
Gap Down
Grow Capital logo
GRWC
Grow Capital
0.6$1.09-8.3%$27.07 million$2.37 million0.00Gap Up
NMUS
Nemus Bioscience
0.6$0.12-0.0%$16.07 millionN/A0.00High Trading Volume
Leafbuyer Technologies logo
LBUY
Leafbuyer Technologies
0.5$0.16-6.5%$14.08 million$2.53 million0.00Gap Up
MassRoots logo
MSRT
MassRoots
0.6$0.02-1.8%$10.91 million$20,000.000.00
Peak Pharmaceuticals logo
PKPH
Peak Pharmaceuticals
0.7$0.13-1.5%$10.19 millionN/A0.00
FutureWorld logo
FWDG
FutureWorld
0.5$0.00-0.0%$4.56 millionN/A0.00Gap Up
Mentor Capital logo
MNTR
Mentor Capital
0.5$0.17-5.9%$3.86 million$4.33 million-4.23Gap Down
NGBL
Notis Global
0.5$0.00-0.0%$3.00 millionN/A0.00
DigiPath logo
DIGP
DigiPath
0.5$0.04-6.1%$2.89 million$2.55 million-1.41Gap Down
CrowdGather logo
CRWG
CrowdGather
0.7$0.01-23.0%$1.60 million$160,000.000.00Increase in Short Interest
Gap Down
United Cannabis logo
CNAB
United Cannabis
0.4$0.01-0.0%$1.23 millionN/A0.00High Trading Volume
OPMZ
1PM Industries
0.4$0.00-0.0%$0.00N/A0.00Gap Down
AQSP
Acquired Sales
0.4$7.90-1.3%$0.00N/A0.00
AMMJ
American Cannabis
0.5$0.19-0.1%$0.00N/A0.00Gap Down
AmeriCann logo
ACAN
AmeriCann
0.4$1.30-0.8%$0.00N/A0.00Gap Up
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18-6.8%$0.00N/A0.00Gap Down
Cannabis Sativa logo
CBDS
Cannabis Sativa
0.5$0.72-1.4%$0.00N/A0.00
FRLF
Freedom Leaf
0.5$0.01-0.0%$0.00N/A0.00High Trading Volume
Gap Up
FUTL
FutureLand
0.4$0.00-0.0%$0.00N/A0.00
GB Sciences logo
GBLX
GB Sciences
0.5$0.05-7.7%$0.00N/A0.00Increase in Short Interest
Gap Down
GreenGro Technologies logo
GRNH
GreenGro Technologies
0.6$0.02-7.6%$0.00N/A0.00News Coverage
Gap Up
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.88-2.0%$0.00N/A0.00Gap Down
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Increase in Short Interest
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.04-8.5%$0.00N/A0.00News Coverage
Gap Up
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00-12.5%$0.00N/A0.00Gap Up
MDCL
Medicine Man Technologies
0.5$2.39-13.0%$0.00N/A0.00High Trading Volume
Northsight Capital logo
NCAP
Northsight Capital
0.5$0.00-60.0%$0.00N/A0.00Gap Down
OWC Pharmaceutical Research logo
OWCP
OWC Pharmaceutical Research
0.6$0.01-2.1%$0.00N/A0.00Gap Down
Surna logo
SRNA
Surna
0.6$0.06-3.1%$0.00N/A0.00Gap Up
Ultrack Systems logo
MJLB
Ultrack Systems
0.6$0.09-3.2%$0.00N/A0.00Gap Up
BUDZ
WEED
0.6$0.52-0.0%$0.00N/A0.00Gap Down
Zoned Properties logo
ZDPY
Zoned Properties
0.6$0.59-2.6%$0.00N/A0.00Gap Down
ZZLL
ZZLL Information Technology
0.4$0.32-0.0%$0.00N/A0.00
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.